Our mandate
MPMED-SEZ exists to convert Tanzania's pharmaceutical import bill into domestic manufacturing capacity, skilled jobs, and export revenue.
The mandate covers four parallel workstreams: building the manufacturing base across two sites; de-risking private investment through incentives and anchored demand; guaranteeing offtake through MSD's USD 491M annual procurement; and opening regional EAC and SADC markets to zone manufacturers.
Every government service an investor needs - registration, regulation, land, and procurement - is coordinated through PIAT as a single point of contact.